Effects of Histone Deacetylase Inhibitor SAHA on Effector and FOXP3+Regulatory T Cells in Rhesus Macaques
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
2002 • 1,497 citations
Deacetylase inhibition promotes the generation and function of regulatory T cells
2007 • 864 citations
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
2001 • 729 citations
Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse
2003 • 385 citations
Histone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice
2006 • 280 citations
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
2005 • 274 citations
Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect
2004 • 264 citations
Trichostatin A attenuates airway inflammation in mouse asthma model
2004 • 181 citations
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses
2003 • 139 citations
Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment.
2002 • 135 citations
Control of gene expression and assembly of chromosomal subdomains by chromatin regulators with antagonistic functions
2005 • 30 citations
Cited By (0)
No citing papers found in database